Join a CureDuchenne event

CureDuchenne has a variety of fundraising events throughout the year. These events have helped us fund seven research projects that have gone to human clinical trials. Join us for Blingo to CureDuchenne on May 3, 2014 in Philadelphia.

Featured event
Upcoming events

Small Luxury Hotels of the World

CureDuchenne is proud to announce Small Luxury Hotels of the World as their national hotel sponsor.

Small Luxury Hotels Website

"Run Away" by Sarah Burgess

Sarah Burgess, singer-songwriter and contestant on the sixth season of American Idol, released a new song called “Run Away” to benefit CureDuchenne.

View the video

Click here to donate

Together, we can CureDuchenne

Duchenne muscular dystrophy is a devastating muscle disease in children, affecting one in every 3,500 male births. Historically, Duchenne boys have not lived beyond their mid-20s. Those that do are faced with progressively weaker muscles and pulmonary and cardiac failure. The potential now exists, however, to make a difference in their quality of life.

Read more

Duchenne families have hope

Hear what Duchenne boys, their parents, and researchers have to say about the experience of living with Duchenne muscular dystrophy.

Watch our video

eDystrophin Database

The eDystrophin database contains information from Duchenne and Becker muscular dystrophy patients searchable by mutation (deletions, duplications and substitutions).

Read more

Duchenne is a progressive, muscle-wasting disease.

It results from a defective gene responsible for producing the key muscle protein, dystrophin. Without dystrophin, cells easily become damaged and die, resulting in heart and breathing failure.

Click here for full image


What is CureDuchenne?

CureDuchenne is a national nonprofit that raises awareness and funds to find a cure for Duchenne muscular dystrophy. The funds we raise support the most promising research programs aimed at treating and curing the disease. For the first time ever there is hope to find a cure for this destructive disease affecting thousands of boys and their families.




Receive Updates

Sign up for our newsletter


Shop for a Cure

All proceeds go to fund CureDuchenne



Research News


Exon skipping drugs will be used to transform Duchenne muscular dystrophy into a much milder disease as seen in Becker muscular dystrophy patients. eDystrophin is an online database that provides information about inframe mutations typically seen in patients with milder forms of the disease. The database has been constructed using patient records and is easy to use and searchable by mutation type or clinical phenotype.

Blingo to CureDuchenne

BLINGO is night of celebrity bingo, bling and celebration where Philadelphians come together to support an incredibly worthy cause – CureDuchenne.

Register Now!

The Latest from the Founder

Summary from Seeking Alpha Based on updated guidance from the FDA regarding an  early approval pathway for eteplirsen, Sarepta Therapeutics (SRPT) plans to file an NDA by the end of 2014. The agency provided specific examples of additional  safety and efficacy data for Duchenne muscular dystrophy that would  enhance the acceptability of the NDA. The company will conduct Read more »

Continue reading

CureDuchenne advocates around the country